Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis

Hu, Mei-Ying and Lu, You-Xun and Lai, Ching-Chong (2022): Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis.

Abstract

Due to the lags in commercialization, the effective life of a patent is generally less than its statutory term. We introduce commercialization lags into the Schumpeterian growth model and explore the effects of patent term extensions on pharmaceutical R&D and social welfare. Our results show that extending patent terms stimulates the consumption of homogeneous goods but generates an ambiguous effect on the consumption of pharmaceuticals. When patent extensions have an inverted-U effect on social welfare, the optimal patent extension increases with the length of commercialization lags but decreases with the input intensity of commercialization lags. Finally, we calibrate the model and find that increasing patent breadth reduces the optimal patent extension.

• Item Type: MPRA Paper
• Language: English
• Keywords: commercialization lags; patent term extensions; pharmaceutical R&D; economic growth; social welfare
• Subjects: I - Health, Education, and Welfare > I1 - Health > I11 - Analysis of Health Care Markets; L - Industrial Organization > L6 - Industry Studies: Manufacturing > L65 - Chemicals ; Rubber ; Drugs ; Biotechnology; O - Economic Development, Innovation, Technological Change, and Growth > O3 - Innovation ; Research and Development ; Technological Change ; Intellectual Property Rights > O31 - Innovation and Invention: Processes and Incentives; O - Economic Development, Innovation, Technological Change, and Growth > O3 - Innovation ; Research and Development ; Technological Change ; Intellectual Property Rights > O34 - Intellectual Property and Intellectual Capital

References

Acemoglu, D. and Linn, J., 2004. Market size in innovation: Theory and evidence from the pharmaceutical industry, Quarterly Journal of Economics, 119, 1049-1090.

Aghion, P. and Howitt, P., 1992. A model of growth through creative destruction, Econometrica, 60, 323-351.

Berndt, E., Mortimer, R., Bhattacharjya, A., Parece, A., and Tuttle, E., 2007. Authorized generic drugs, price competition, and consumers’ welfare. Health Affairs, 26, 790-799.

Budish, E., Roin, B., and Williams, H., 2015. Do firms underinvest in long-term research? Evidence from cancer clinical trials. American Economic Review, 105, 2044-2085.

Budish, E., Roin, B., and Williams, H., 2016. Patents and research investments: Assessing the empirical evidence. American Economic Review: Papers and Proceedings, 106, 183-187.

Chu, A., 2008. Special interest politics and intellectual property rights: An economic analysis of strengthening patent protection in the pharmaceutical industry. Economics and Politics, 20, 185-215.

Chu, A., 2009. Effects of blocking patents on R&D: A quantitative DGE analysis. Journal of Economic Growth, 14, 55-78.

Chu, A., 2021. Patent policy and economic growth: A survey. The Manchester School, 90, 237-254.

Chu, A., and Cozzi, G., 2018. Effects of patents versus R&D subsidies on income inequality. Review of Economic Dynamics, 29, 68-84.

Chu, A., Furukawa, Y., Mallick, S., Peretto, P., and Wang, X., 2021. Dynamic effects of patent policy on innovation and inequality in a Schumpeterian economy. Economic Theory, 71, 1429-1465.

Chu, A., and Pan, S., 2013. The escape-infringement effect of blocking patents on innovation and economic growth. Macroeconomic Dynamics, 17, 955-969.

Cozzi, G., and Galli, S., 2014. Sequential R&D and blocking patents in the dynamics of growth. Journal of Economic Growth, 19, 183-219.

Cozzi, G., Giordani, P., and Zamparelli, L., 2007. The refoundation of the symmetric equilibrium in Schumpeterian growth models. Journal of Economic Theory, 136, 788-797.

Danzon, P., Nicholson, S., and Pereira, N., 2005. Productivity in pharmaceutical-biotechnology R&D: The role of experience and alliances. Journal of Health Economics, 317-339.

DiMasi, J., Grabowski, H., and Hansen, R., 2016. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20-33.

Dinopoulos, E., Gungoraydinoglu, A., and Syropoulos, C., 2007. Patent protection and global Schumpeterian growth, in: E. Dinopoulos, P. Krishna, A. Panagariya, and K. Wong, eds., Trade Globalization and Poverty (Routledge, New York).

Dinopoulos, E., and Thompson, P., 1998. Schumpeterian growth without scale effects. Journal of Economic Growth, 3, 313-335.

Furukawa, Y., 2007. The protection of intellectual property rights and endogenous growth: Is stronger always better? Journal of Economic Dynamics and Control, 31, 3644-3670.

Futagami, K., and Iwaisako, T., 2007. Dynamic analysis of patent policy in an endogenous growth model. Journal of Economic Theory, 132, 306-334.

Gaessler, F., and Wagner, S., 2019. Patents, data exclusivity, and the development of new drugs. The Review of Economics and Statistics, 1-49.

Goh, A., and Olivier, J., 2002. Optimal patent protection in a two-sector economy. International Economic Review, 43, 1191-1214.

Gong, H., and Peng, S., 2018. Effects of patent policy on innovation outputs and commercialization: Evidence from universities in China. Scientometrics, 117, 687-703.

Grabowski, H., and Kyle, M., 2007. Generic competition and market exclusivity periods in pharmaceuticals. Managerial and Decision Economics, 28, 491-502.

Grinols, E., and Lin, H., 2011. Patent replacement and welfare gains. Journal of Economic Dynamics and Control, 35, 1586-1604.

Grossman, G. M., and Helpman, E., 1991. Quality ladders in the theory of growth. Review of Economic Studies, 58, 43-61.

Grossman, G., and Lai, E., 2004. International protection of intellectual property. American Economic Review, 94, 1635-1653.

Hay, M., Thomas, D., Craighead, J., Economides, C., and Rosenthal J., 2014. Clinical development success rates for investigational drugs. Nature Biotechnology, 32, 40-51.

Higgins, M., and Graham, S., 2009. Balancing innovation and access: Patent challenges tip the scales. Science, 326, 370-371.

Horowitz, A., and Lai, E., 1996. Patent length and the rate of innovation. International Economic Review, 37, 785-801.

Howitt, P., 1999. Steady endogenous growth with population and R&D inputs growing. Journal of Political Economy, 107, 715-730.

Huang, W., Lai, C., and Chen, P., 2017. International R&D funding and patent collateral in an R&D-based growth model. International Review of Economics and Finance, 51, 545-561.

Huang, C., Yang, Y., and Cheng, C., 2017. The growth and welfare analysis of patent and monetary policies in a Schumpeterian economy. International Review of Economics and Finance, 52, 409-426.

Iwaisako, T., 2020. Welfare effects of patent protection in a semi-endogenous growth model. Macroeconomic Dynamics, 24, 708-728.

Iwaisako, T., and Futagami, K., 2003. Patent policy in an endogenous growth model. Journal of Economics, 78, 239-258.

Jones, C., 1995a. Time series tests of endogenous growth models. Quarterly Journal of Economics, 110, 495-525.

Jones, C., 1995b. R&D-based models of economic growth. Journal of Political Economy, 103, 759-784.

Jones, C., 1999. Growth: With or without scale effects. American Economic Review Papers and Proceedings, 89, 139-144.

Jones, C., and Williams, J., 2000. Too much of a good thing? The economics of investment in R&D. Journal of Economic Growth, 5, 65-85.

Judd, K., 1985. On the performance of patents, Econometrica, 53, 567-586.

Kiedaisch, C., 2015. Intellectual property rights in a quality-ladder model with persistent leadership. European Economic Review, 80, 194-213.

Koléda, G., 2004. Patents’ novelty requirement and endogenous growth. Revue d’économie politique, 114, 201-221.

Kwan, Y., and Lai, E., 2003. Intellectual property rights protection and endogenous economic growth. Journal of Economic Dynamics and Control, 27, 853-873.

Lin, H., and Shampine, L., 2018. R&D-based calibrated growth models with finite-length patents: A novel relaxation algorithm for solving an autonomous FDE system of mixed type. Computational Economics, 51, 123-158.

Lu, Y., and Lai, C., 2022. Effects of patent policy on growth and inequality: Exogenous versus endogenous quality improvements. MPRA Paper No. 111695.

Mossinghoff, G., 1999. Overview of the Hatch-Waxman Act and its impact on the drug development process. Food and Drug Law Journal, 54, 187-194.

Niwa, S., 2016. Patent claims and economic growth. Economic Modelling, 54, 377-381.

Niwa, S., 2018. Effects of a blocking patent on R&D with endogenous survival activities. Journal of Economics, 125, 263-277.

O’Donoghue, T., and Zweimuller, J., 2004. Patents in a model of endogenous growth. Journal of Economic Growth, 9, 81-123.

Panattoni, L., 2011. The effect of paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms. Journal of Health Economics, 30, 126-145.

Peretto, P., 1998. Technological change and population growth. Journal of Economic Growth, 3, 283-311.

Pessoa, A., 2005. “Idea” driven growth: The OECD evidence. Portuguese Economic Journal, 4, 46-67.

Philipson, T., and Sun, E., 2008. Is the food and drug administration safe and effective? Journal of Economic Perspectives, 22, 85-102.

Porter M., and Stern S., 2000. Measuring the “Ideas” production function: Evidence from international patent output. NBER working Paper 7891.

Saha, A., Grabowski, H., Birnbaum, H., Greenberg, P., and Bizan, O., 2006. Generic Competition in the US Pharmaceutical Industry. International Journal of the Economics of Business, 13, 15-38.

Sanso, M., and Aisa, R., 2006. Endogenous longevity, biological deterioration and economic growth. Journal of Health Economics, 25, 555-578.

Segerstrom, P., 1998. Endogenous growth without scale effects. American Economic Review, 1290-1310.

Sloan, F., and Hsieh, C., 2017. Health Economics (2nd ed.). Cambridge: The MIT Press.

Wagner, S., and Wakeman, S., 2016. What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry. Research Policy, 45, 1091-1102.

Yang, Y., 2018. On the optimality of IPR protection with blocking patents. Review of Economic Dynamics, 27, 205-230.

Yang, Y., 2021. Welfare effects of patent protection in a growth model with R&D and capital accumulation. Macroeconomic Dynamics, 25, 579-602.

Zeng, J., Zhang, J., and Fung, M., 2014. Patent length and price regulation in an R&D growth model with monopolistic competition. Macroeconomic Dynamics, 18, 1-22.